Prostate-specific Membrane Antigen: A Novel Folate Hydrolase in Human Prostatic Carcinoma Cells

Clinical Cancer Research

Volumn 2, Issue 9, 1996, Pages 1445-1451

  Pinto, John T ^a   Suffoletto, Brian P ^a   Berzin, Tyler M ^a   Qiao, Chang Hong ^a   Lin, Silan ^a   Tong, William P ^a   May, Florian ^a   Mukherjee, Bhaskar ^a   Heston, Warren D W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE; DRUG DERIVATIVE; FOLIC ACID; GAMMA GLUTAMYL HYDROLASE; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; HYDROLASE; MEMBRANE ANTIGEN; METHOTREXATE; METHOTREXATE POLYGLUTAMATE; POLYGLUTAMIC ACID; PTEROPTIN; PTEROYLPENTAGLUTAMIC ACID;

ARTICLE; CELL CULTURE; CELL FRACTIONATION; CELL MEMBRANE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; ENZYME SPECIFICITY; ENZYMOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; PH; PROSTATE TUMOR;

ANTIGENS, SURFACE; CARBOXYPEPTIDASES; CELL FRACTIONATION; CELL MEMBRANE; FOLIC ACID; GAMMA-GLUTAMYL HYDROLASE; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROLASES; IMMUNOHISTOCHEMISTRY; MALE; METHOTREXATE; POLYGLUTAMIC ACID; PROSTATIC NEOPLASMS; PTEROYLPOLYGLUTAMIC ACIDS; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0030223004     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Israeli, R. S., Powell, C. T., Fair, W. R., and Heston, W. D. W. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53: 227-230, 1993.
2. Israeli, R. S., Powell, C. T , Corr, J. G., Fair, W. R., and Heston, W. D. W. Expression of the prostate-specific membrane antigen. Cancer Res., 54: 1807-1811, 1994.
3. Su, S. L. Huang, I-P, Fair, W. R., Powell C. T., and Heston, W. D. W. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res., 55: 1441-1443, 1995.
4. Schneider, C., Owen, M. J., Banville, D., and Williams, J. G. Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature (Lond.), 311: 675-678, 1984.
5. von Heijne, G. Transcending the impenetrable: how proteins come to terms with membranes. Biochim. Biophys. Acta, 947: 307-333, 1991.
6. Collawn, J. F., Lai, A., Domingo, D., Fitch, M., Hatton, S., and Trowbridge, I. S. YTRF is the conserved internalization signal of the transferrin receptor and a second YTRF signal at position 31-34 enhances endocytosis J Biol. Chem., 268: 21686-21692, 1993.
7. Donat, S. M., Powell, C. T., Israeli, R. S., Fair, W. R., and Heston, W. D. W. Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells. J. Natl. Cancer Inst , 87: 41-46, 1995.
8. Chandler, C. J., Wang, T. T. Y., and Halsted, C. H. Pteroylpolyglutamate hydrolase from human jejunal brush borders: purification and characterization. J. Biol. Chem., 267: 928-933, 1986.
9. Holm, J., Hansen, S. I., and Hoier-Madsen, M. High-affinity folate binding in human prostate. Biosci. Rep., 13: 99-105, 1993.
10. Tong, W. P., Lin, S., Li, W. W., Waltham, M., Goker, E., and Bertino J. R. Capillary electrophoresis of methotrexate polyglutamates and its application in evaluation of folylpolyglutamate hydrolase activity. Proc. Am. Assoc. Cancer Res., 35: 304, 1994.
11. Yao, R., Nimec, Z., Ryan, T. J., and Galivan, J. Identification, cloning, and sequencing of a cDNA coding for rat γ-glutamyl hydrolase. J. Biol. Chem., 271: 8525-8528, 1996.
12. Carter, R. E., Feldman, A. R., and Coyle, J. T. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc. Natl. Acad. Sci. USA, 93: 749-753, 1996.
13. Horoszewicz, J. S., Kawinski, E., and Murphy, G. P. Monoclonal antibodies to a new antigenic marker in epithelial cells and serum of prostatic cancer patients. Anticancer Res., 7: 927-936, 1987.
14. 111indium labeled cyt-356 for the delection of occult prostate cancer recurrence. J. Urol., 152: 1490-1495, 1994.
15. Lowe, K. E., Osborne, C. B., Lin, B-F., Kim, J-S., Hsu, J-C., and Shane, B. Regulation of folate and one-carbon metabolism in mammalian cells. II. Effect of folylpoly-γ-glutamate synthetase substrate specificity and level on folate metabolism and folylpoly-γ-glutamate specificity of metabolic cycles on one-carbon metabolism. J. Biol. Chem., 268: 21665-21673, 1993.
16. Banerjee, D., Ercikan-Abali, E., Waltham, M., Schnieders, B., Hochhauser, D., Lei, W. W., Fan, J., Gorlick, R., Goker, E., and Bertino, J. R. Molecular mechanisms of resistance to antifolates, a review. Acta Biochim. Pol., 42: 457-464, 1995.
17. Rhee, M. S., Wang, Y., Nair, M. G., and Galivan, J. Acquisition of resistance to antifolates caused by enhanced γ-glutamyl hydrolase activity. Cancer Res., 53: 2227-2230, 1993.
18. Li, W. W., Waltham, M., Tong, W., Schweitzer, B. I., and Bertino, J. R. Increased activity of γ-glutamyl hydrolase in human sarcoma cell lines: a novel mechanism of intrinsic resistance to methotrexate (MTX). Adv. Exp. Med. Biol., 338: 635-638, 1993.
19. Scher, H., and Sternberg, C. N. Chemotherapy of urologic malignancies. Semin. Urol., 3: 329-381, 1985.
20. Asakura, M., Nagahashi, Y., Hamada, M., Kawai, M., Kadobayashi, K., Narahara, M., Nakagawa, Y., Kawai, Y., Hama, T., and Miyake, M. Purification and properties of β-citryl-L-glutamate-hydrolyzing enzyme from rat testis particulate. Biochim. Biophys. Acta, 1250: 35-42, 1995.
21. Fuhrman, S., Palkovits, M., Cassidy, M., and Neale, J. H. The regional distribution of N-acetylaspartylglutamate (NAAG) and peptidase activity against NAAG in the rat nervous system. J. Neurochem., 62: 275-281, 1994.
22. Slusher, B. S., Robinson, M. B., Tsai, G., Simmons, M. L., Richards, S. S., and Coyle, J. T. Rat brain linked N-acetylated α-linked acidic dipeptidase activity: purification and immunologic characterization. J. Biol. Chem., 265: 21297-21301, 1990.
23. Aprikian, A. G., Cordon-Cardo, C., Fair, W. R., and Reuter, V. E. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer (Phila.), 71: 3952-3965, 1993.
24. Yatani, R., Kusano, I., Shiraishi, T, Hayashi, T., and Stemmermann, G. N. Latent prostatic carcinoma: pathological and epidemiological aspects. Jpn. J. Clin. Oncol., 19: 319-326, 1989.
25. Meropol, N. J., Creaven, P. J., Petrelli, N. J., White, R. M., and Arbuck, S. G. Seizures associated with leucovorin administration in cancer patients. J. Natl. Cancer Inst., 87: 56-58, 1995.